Monographie - Methylprednisolone acetate - Stabilis 4.0

Son güncelleme :
05/12/2025

Antienflamatuvar

Methylprednisolone acetate

Enjeksiyon

Çözeltilerin stabilitesi

Karışımlardaki stabilitesi

Stabiliteyi etkileyen faktörler

Uyumluluk

Uygulama yöntemi

Kaynaklar

pdf

Kimyasal yapı

Ticari isim

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cipridanol	Kolombiya
Cryosolona	Meksika
Depo Medrol	Amerika Birleşik Devletleri, Avustralya, Belçika, Birleşik Arap Emirlikleri, Brezilya, Büyük Britanya, Danimarka, Finlandiya, Fransa, Hırvatistan, Hollanda, İspanya, İsveç, İsviçre, İtalya, Kanada, Macaristan, Mısır, Norveç, Polonya, Portekiz, rusça, Şili, Suudi Arabistan, Türkiye, Yunanistan
Depo Medrone	İrlanda
Depo Provera	Fransa
Depopred	Amerika Birleşik Devletleri, Hindistan
Solumet	Peru

Kaynaklar

Enjeksiyon

Kaynaklar : Methylprednisolone acetate

	tip	yayın
1085	Dergi	Irving HD, Burbridge BE. Incompatibility of contrast agents with intravascular medications. Radiology 1989 ; 173: 91-92.
1620	Dergi	Saverio Robustelli della Cuna F, Mella M, Magistrali G, Ricci M, Losurdo A, Goglio AM. Stability and compatibility of methylprednisolone acetate and ropivacaine hydrochloride in polypropylene syringes for epidural administration. Am J Health-Syst Pharm 2001 ; 58: 1753-1756.
2109	Dergi	Pelletier E, Forest JM, Hildgen P. Compatibilité de la kétamine injectable lors de l’administration en dérivé avec d’autres médicaments usuels. Pharmactuel 2006 ; 39: 71-75.
2261	Dergi	Fernandez C, Pelloquin A, Berthoume M, Bellanger A, Farinotti R. Stabilité et compatibilité de l'association ondansétron-méthylprednisolone en solution. Can J Hosp Pharm 2008 ; 61, 3: 191-195.
3408	Dergi	Tollec S, Touzin K, Pelletier E, Forest J.M. Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Pharmactuel 2013 ; 46, 1 : 16-21.
3545	Laboratuar	Amoxicilline / acide clavulanique - Résumé des caractéristiques du produit Mylan SAS 2009
3604	Laboratuar	Daunorubicine (Cérubidine®) - Résumé des caractéristiques du produit Sanofi Aventis France 2012
4528	Dergi	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61

Mentions Légales